A First-time-in-human, Randomised, Double-blind, Placebo-controlled, Parallel-group Study in Healthy Volunteers and Patients With Asthma to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending and Repeat Doses of PIN201104
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2018
At a glance
- Drugs PIN 201104 (Primary) ; PIN 201104 (Primary)
- Indications Asthma
- Focus Adverse reactions; First in man
- Sponsors Peptinnovate
- 23 Jan 2018 Status changed from recruiting to completed.
- 19 Sep 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.
- 19 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.